Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

|

Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV ...

South Africa Time — Monday, June 01, 2026

In a multicenter cross-sectional study of 1308 people with HIV and chronic hepatitis B, adherence to hepatocellular carcinoma ...

View article...

Racial Xperience

Top stories of the last 30 days

Introduction of HAART Partially Responsible for Resurgence in Syphilis

South Africa Time — Monday, May 04, 2026

... HIV from a terminal condition into a manageable chronic disease. To test this empirically, variation in HAART uptake was exploited based on ... View article...

Misinformation threatens rollout of HIV prevention drug lenacapavir

South Africa Time — Wednesday, May 27, 2026

Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South Africa. View article...

Misinformation is coming for the anti-HIV jab. Let's get ahead of it

South Africa Time — Monday, May 25, 2026

A new HIV prevention injection could change the course of the epidemic — but only if people trust it. Research shows we can pre-empt the false ... View article...

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain

South Africa Time — Tuesday, May 05, 2026

Use of Gilead Sciences' Yeztugo, a twice-yearly injection to prevent HIV infection, has climbed since its June ... View article...

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA ...

South Africa Time — Wednesday, May 27, 2026

... HIV infection, with over 44.1 million people living with HIV globally. While antiretroviral therapy can effectively control HIV replication, it ... View article...

Against all odds: 42-year-old woman defeats HIV, hepatitis B and cancer with rare liver transplant

South Africa Time — Monday, May 25, 2026

For years, individuals suffering from HIV along with serious liver disease or cancer were regarded as inappropriate candidates for undergoing an ... View article...

Small study hints that revving up immune cells might help fight HIV

South Africa Time — Thursday, May 14, 2026

Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs. A small study is hinting that CAR-T cell ... View article...

Emory joins initiative expanding HIV prevention access

South Africa Time — Thursday, May 14, 2026

Dr. Natalie Crawford discusses a new effort helping pharmacies expand HIV prevention services as Georgia broadens access to medication. View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Misinformation threatens rollout of HIV prevention drug lenacapavir

South Africa Time — Wednesday, May 27, 2026

Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South Africa. View article...

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA ...

South Africa Time — Wednesday, May 27, 2026

... HIV infection, with over 44.1 million people living with HIV globally. While antiretroviral therapy can effectively control HIV replication, it ... View article...

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV ...

South Africa Time — Thursday, May 28, 2026

Broadly neutralizing antibodies (bnAbs) against HIV-1 are promising components of long-acting antiretroviral treatment (ART) due to their ... View article...

One community health worker's mission to stop advanced HIV disease in Uganda

South Africa Time — Wednesday, May 27, 2026

CD4 testing works alongside another tool Margaret relies on: viral load testing, which measures the amount of HIV in the blood. The two tests answer ... View article...

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients ...

South Africa Time — Thursday, May 28, 2026

In this study, HIV-infected patients who are receiving antiretroviral therapy for HIV will receive either maraviroc or a placebo (sugar pill) each day ... View article...

NSW aims to end HIV transmission by 2030 with new plan

South Africa Time — Wednesday, May 27, 2026

NSW is aiming to further strengthen prevention, testing, treatment and support of HIV with a new strategy announced today. View article...

Integrating HIV Prevention Tools for Men

South Africa Time — Thursday, May 28, 2026

HIV continues to be a major public health challenge in Sub-Saharan Africa, where a large share of global infections still occur. View article...

Consistency in causal reasoning for large language models in scenarios of HIV antiretroviral ...

South Africa Time — Thursday, May 28, 2026

LLMs were prompted with context-rich clinical and causal vignettes to generate use cases, followed by context-simple ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews